NIH-funded research R01 grant

How maternal substance use affects child brain development

Official title: Impact of maternal substance use on offspring neurobehavioral development

Funded at Massachusetts General Hospital · NIH-10750254 · Data updated 2026-11-12

This study is looking at how using substances like opioids, cannabis, and alcohol during pregnancy affects how children grow and develop, especially their brain and behavior, to help understand any challenges they might face later on.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$6,439,263
NIH project number1R01HD113188-01
Project IDNIH-10750254 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include pregnant individuals who have used substances such as opioids, cannabis, or alcohol during their pregnancy.

Less likely to help

Patients who have not used any substances during pregnancy or whose children are not exhibiting neurodevelopmental issues may not benefit from this research.

What this research studies

This research investigates the effects of substance use during pregnancy on the neurobehavioral development of children. It focuses on understanding how maternal immune activation, triggered by the use of opioids, cannabis, and alcohol, impacts the development of the child's brain and behavior. By analyzing data from a large cohort of mother-child pairs, the study aims to uncover the mechanisms linking maternal substance use to developmental issues such as cognitive dysfunction and mood disorders. The research will also explore the role of the placenta in these processes, providing insights into potential interventions.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and interventions for neurodevelopmental disorders in children exposed to substances in utero.

How similar studies have gone: Other research has shown promising results in understanding the impact of maternal substance use on child development, making this study a continuation of important work in this field.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Edlow, Andrea Goldberg — Massachusetts General Hospital
  • Study coordinator: Edlow, Andrea Goldberg

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.